Status and clinical utility of pharmaconutrients

Current Opinion in Critical Care

Volumn 2, Issue 4, 1996, Pages 253-259

  Minard, Gayle ^a   Janu, Peter ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008400582     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199608000-00002     Document Type: Article

References (85)

1. Fürst P: New parenteral substrates in clinical nutrition: part I. Introduction: new substrates in protein nutrition. J Clin Nutr 1994, 48:607-616.
2. McNurlan MA, Garlick PJ: Protein and amino acids in nutritional support. Crit Care Clin 1995, 11:635-650.
3. Ardawi MSM, Newsholme EA: Metabolism in lymphocytes and its importance in the immune response. Essays Biochem 1985, 21:1-44.
4. Pastores SM, Kvetan V, Katz DP: Immunomodulatory effects and therapeutic potential of glutamine in the critically ill surgical patient. Nutrition 1994, 10:385-391.
5. Gianotti L, Alexander JW, Gennari R, Pyles T, Babcock GF: Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr 1995, 19:69-74. In a burn model, mice fed glutamine showed reduced bacterial translocation and an increased ability to kill translocated bacteria compared with animals fed chow or chow plus glycine.
6. Fujita T, Sakurai K: Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg 1995, 82:749-751.
7. Dugan MER, McBurney MI: Luminal glutamine perfusion alters endotoxin-related changes in ileal permeability of the piglet. JPEN J Parenter Enteral Nutr 1995, 19:83-87.
8. Denno R, Rounds JD, Faris R, Holejko LB, Wilmore DW: Glutamine-enriched total parenteral nutrition enhances plasma glutathione in the resting state. Surg Res 1996, 61:35-38.
9. Rouse K, Nwokedi E, Woodliff JE, Epstein J, Klimberg VS: Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg 1995, 221:420-426. In a fibrosarcoma model, oral administration of glutamine maintained whole body glutathione levels despite methotrexate administration. Tumor load and tumor glutathione levels were decreased.
10. Carroll MKP, Zera RT, Roberts JC, Schlafmann SE, Feeney DA, Johnston GR, West MA, Bubrick MP: Efficacy of radioprotective agents in preventing small and large bowel radiation injury. Dis Colon Rectum 1995, 38:716-722.
11. Jensen JC, Schaefer R, Nwokedi E, Bevans DW, Baker ML, Pappas AA, Westbrook KC, Klimberg VS: Prevention of chronic radiation enteropathy by dietary glutamine. Ann Surg Oncol 1994, 1:157-163.
12. Yoshida S, Yunoki T, Aoyagi, Ohta J, Ishibashi N, Noake T, Kakegawa T: Effect of glutamine supplement and hepatoectomy on DNA and protein synthesis in the remnant liver. J Surg Res 1995, 59:475-481.
13. Blomqvist BI, Hammarqvist F, von der Decken A, Wernerman J: Glutamine and α ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement. Metabolism 1995, 44:1215-1222.
14. van der Hulst RRW, von Meyenfeldt MF, Deutz NEP, Stockbrügger RW, Soeters PB: The effect of glutamine administration on intestinal glutamine content. Surg Res 1996, 61:30-34.
15. Fang CH, James JH, Fischer JE, Hasselgren PO: Is muscle protein turnover regulated by intracellular glutamine during sepsis? JPEN J Parenter Enteral Nutr 1995, 19:279-285. Rat extensor digitorum longus muscles were incubated with or without glutamine. Protein synthesis was not altered; however, there was an increased rate of myofibrillar protein breakdown despite glutamine levels well above normal.
16. Gardiner KR, Ahrendt GM, Gardiner RE, Barbul A: Failure of intestinal amino acid absorptive mechanisms in sepsis. J Am Coll Surg 1995, 181:431-436. Uptake of amino acids across everted jejunal sacs was studied in two different rat sepsis models. All amino acids tested demonstrated decreased absorption.
17. Long CL, Borghesi L, Stahl R, Clark JA, Geiger JW, DiRienzo DB, Weis JK, Laws HL, Blakemore WS: Impact of enteral feeding of a glutamine-supplemented formula on the hypoaminoacidemic response in trauma patients. J Trauma Injury Infect Crit Care 1996, 40:97-102.
18. +-dependent hepatic amino acid transport. JPEN J Parenter Enteral Nutr 1995, 19:9-14.
19. MacBurney M, Young LS, Ziegler TR, Wilmore DW: A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Diet Assoc 1994, 94:1263-1266.
20. Schloerb PR, Amare M: Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993, 17:407-413.
21. van Zaanen HCT, van der Lelie H, Timmer JG, Fürst P, Sauerwein HP: Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cander 1994, 74:2879-2884.
22. Mattox TW, Bertch KE, Mirtallo JM, Strausberg KM, Cuddy PG: Recent advances: parenteral nutrition support. Ann Pharmacother 1995, 29:174-180.
23. Elsair J, Poey J, Issad H: Effect of arginine chlorohydrate on nitrogen balance during the three days following routine surgery in man. Biomedicine 1978, 29:312-317.
24. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G: Argine enhances wound healing and lymphocyte immune responses in humans. Surgery 1990, 108:331-336.
25. Barbul A, Knud-Hansen J, Wasserkrug HL, Efron G: Interleukin 2 enhances wound healing in rats. J Surg Res 1986, 40:315-319.
26. Madden HP, Breslin RJ, Wasserkrug HL, Efron G, Barbul A: Stimulation of T cell immunity by arginine enhances survival in peritonitis. J Surg Res 1988, 44:658-663.
27. Gardiner KR, Gardiner RE, Barbul A: Reduced intestinal absorption of arginine during sepsis. Crit Care Med 1995, 23:1227-1232.
28. Hurson M, Regan MC, Kirk SJ, Wasserkrug HL, Barbul A: Metabolic effects of arginine in a healthy elderly population. JPEN J Parenter Enteral Nutr 19:227-230. Healthy elderly patients were randomly assigned to receive arginine supplementation or placebo. Study patients demonstrated slightly increased blood urea nitrogen, decreased serum potassium, and increased nitrogen balance.
29. Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, Ruggleri B: Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988, 208:512-523.
30. Gottschlich MM, Jenkins M, Warden GD, Baumen T, Havens P, Snook JT, Alexander JW: Differential effects of 3 enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 1990, 14:225-236.
31. Adjei AA, Yamauchi K, Nakasone Y, Konishi M, Yamamoto S: Arginine-supplemented diets inhibit endotoxin-induced bacterial translocation in mice. Nutrition 1995, 11:371-174.
32. Di Lorenzo M, Bass J, Krantis A: Use of L-arginine in the treatment of experimental necrotizing enterocolitis. J Pediatr Surg 1995, 30:235-240.
33. Gaboury J, Woodman rC, Granger DN, Reinhardt P, Kubes P: Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993, 265:862-867.
34. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995, 37:247-255.
35. Clandinin MT, Jumpsen J, Suh M: Relationship between fatty acid accretion, membrane composition, and biologic functions. J Pediatr 1994, 125:S25-S32.
36. Gogos C, Kalfarentzos F: Total parenteral nutrition and immune system activity: a review. Nutrition 1995, 11:339-344.
37. Ayala A, Chaudry IH: Dietary n-3 polyunsaturated fatty acid modulation of immune cell function before or after trauma. Nutrition 1995, 11:1-11.
38. Britton J: Dietary fish oil and airways obstruction. Thorax 1995, 50(suppl 1):511-515. Studies of the effects of fish oil on chronic obstructive pulmonary disease were reviewed. Fish oil does not appear to be protective except in smokers.
39. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR, et al.: Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1995, 38:1107-1114.
40. Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F: Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc 1995, 27:846-849.
41. Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR: Delayed omega-3 fatty acid supplements in renal transplantation: a double-blind, placebo-controlled study. Transplantation 1995, 59:352-356.
42. Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Florida A, Firenze C, Albverti A, Di Benedetto D, Stragliotto E: Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 1995, 56:143-153.
43. Herrmann W, Biermann J, Kostner GM: Comparison of effects of n-3 to n-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease. Am J Cardiol 1995, 76:459-462.
44. Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M: Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation. Scand J Clin Lab Invest 1995, 55:295-300.
45. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC: Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol 1995, 25:1492-1498. Patients with coronary artery disease documented by angiography were randomly assigned to receive fish oil or placebo. Study patients showed decreases in cholesterol and triglycerides but no difference in progression of heart disease.
46. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989, ii:757-761.
47. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
48. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995, 332:977-982. Male health professionals who had completed detailed history and health questionnaires were followed up for 6 years. Increasing servings of fish did not reduce the risk of coronary artery disease.
49. Goodnight SH, Cairns JA: Therapeutic use of n-3 fatty acids for vascular disease and thrombosis. Chest 1995, 108:302S-304S.
50. Heyland DK, Cook DJ, Guyatt GH: Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical review of the evidence. Crit Care Med 1994, 22:1192-1202.
51. Carver JD, Cox WI, Barness LA: Dietary nucleotide effects upon murine natural killer cell activity and macrophage activation. JPEN J Parenter Enteral Nutr 1990, 14:18-22.
52. Matsumoto Y, Adjei AA, Yamauchi K, Kise M, Yokoyama H, Shinagawa Y, Yamamoto S: Nucleoside-nucleotide mixture increases peripheral neutrophils in cyclophosphamide-induced neutropenic mice. Nutrition 1995, 11:296-299.
53. van Buren CT, Rudolph FB, Kulkarni A, Pizzini R, Fanslow WC, Kumar S: Reversal of immunosuppression induced by a protein-free diet: comparison of nucleotides, fish oil, and arginine. Crit Care Med 1990, 18:S114-S117.
54. Rudolph FB, Kulkarni AD, Schandle VB, Van Buren CT: Involvement of dietary nucleotides in T lymphocyte function. Adv Exp Med Biol 1984, 165B:175-178.
55. Fanslow WC, Kulkarni AD, Van Buren CT, Rudolph FB: Effect of nucleotide restriction and supplementation on resistance to experimental murine candidiasis. JPEN J Parenter Enteral Nutr 1988, 12:49-52.
56. Kulkarni AD, Fanslow WC, Rudolph FB, Van Buren CT: Effect of dietary nucleotides on responses to bacterial infections. JPEN J Parenter Enteral Nutr 1986, 10:169-171.
57. Adjei AA, Takamine F, Yokoyama H, Shiokawa K, Matsumoto Y, Asato L, Shjinjo S, Imamura T, Yamamoto S: The effects of oral RNA and intraperitoneal nucleoside-nucleotide administration on methicillin-resistant Staphylococcus aureus infection in mice. JPEN J Parenter Enteral Nutr 1993, 17:148-152.
58. Chiba T, Uchida T, Hayashi Y, Ohi R, Kasai M: Effects of nucleosides on nitrogen metabolism in mammalian tissues. JPEN J Parenter Enteral Nutr 1985, 9:118.
59. Ziegler TR, Leader I: Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients. Semin Respir Infect 1994, 9:240-247.
60. Melarvie S, Jeevanandam M, Holaday NJ, Petersen SR: Pulsatile nature of growth hormone levels in critically ill trauma victims. Surgery 1995, 117:402-408.
61. Jeevanandam M, Holaday NJ, Petersen SR: Plasma levels of insulin-like growth factor binding protein-3 in acute trauma patients. Metabolism 1995, 44:1205-1208.
62. Petersen SR, Holaday NJ, Jeevanandam M: Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994, 36:726-733.
63. Petersen SR, Holaday NJ: Adjuvant recombinant human growth hormone stimulates insulin-like growth factor binding protein-3 secretion in critically ill trauma patients. J Trauma Injury Infect Crit Care 1995, 39:295-302.
64. Jeevanandam M, Ali MR, Holaday NJ, Petersen SR: Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. JPEN J Parenter Enteral Nutr 1995, 19:137-144.
65. Jeevanandam M, Petersen SR: Altered lipid kinetics in adjuvant recombinant human growth hormone-treated multiple-trauma patients. Am J Physiol 1994, 267:E560-E565.
66. Behrman SW, Kudsk KA, Brawn RO, Vehe KL, Wojtysiak SL: The effect of growth hormone on nutritional markers in enterally fed immobilized trauma patients. JPEN J Parenter Enteral Nutr 1995, 19:41-46.
67. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 1995, 47:876-883.
68. Voerman BJ, van Schijndel RJMS, Groeneveld ABJ, de Boer H, Nauta JP, Thijs LG: Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med 1995, 23:665-673. Patients randomly assigned to GH therapy had transient improvements in nitrogen balance unrelated to changes in IGF.
69. Tayek JA, Brasel JA: Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study. J Clin Endocrinol Metab 1995, 80:2082-2087.
70. Wong WK, Soo KC, Nambiar R, Tan YS, Yo SL, Tan IK: Effect of recombinant growth hormone on nitrogen balance in malnourished patients after major abdominal surgery. Aust N Z J Surg 1995, 65:109-113.
71. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW: Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995, 19:296-302.
72. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW: A new treatment for patients with short-bowel syndrome. Ann Surg 1995, 222:243-255. Patients with short-bowel syndrome were treated with glutamine, a high-carbohydrate, low-fat diet, and GH. Patients showed improved protein absorption, decreased stool output, and reduced requirements for TPN.
73. Zhao X, Unterman TG, Donovan SM: Human growth hormone but not human insulin-like growth factor-I enhances recovery from neonatal malnutrition in rats. J Nutr 1994, 125:1316-1327.
74. Lo H-C, Hinton PS, Peterson CA, Ney DM: Simultaneous treatment with IGF-I and GH additively increases anabolism in parenterally fed rats. Am J Physiol 1995, 269:E368-E376.
75. Zhao X, Donovan SM: Combined growth hormone (GH) and insulin-like growth factor-1 (IGF-1) treatment is more effective than GH or IGF-I alone at enhancing recovery from neonatal malnutrition in rats. J Nutr 1995, 125:2773-2786.
76. Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y: Insulin-like growth factor-1 prevents gut atrophy and maintains intestinal integrity in septic rats. JPEN J Parenter Enteral Nutr 1995, 19:119-124.
77. Malmlöf, K, Corlova Z, Saxerholt H, Karlsson E, Arrhenius-Nyberg V, Skottner A: Effects of insulin-like growth factor 1 and growth hormone on the net flux of amino acids across the hind limbs in the surgically traumatized pig. Clin Sci 1995, 88:285-292.
78. Ketelslegers J-M, Maiter D, Maes M, Underwood LE, Thissen J-P: Nutritional regulation of insulin-like growth factor-1. Metabolism 1995, 44:50-57. Detailed review of the pathophysiologic changes in GH and IGF in conditions of malnutrition and protein restriction in both human and animal models.
79. Gennari R, Alexander W, Eaves-Pyles T: Effect of different combinations of dietary additives on bacterial translocation and survival in gut-deprived sepsis. JPEN J Parenter Enteral Nutr 1995, 19:319-325. Different combinations of glutamine, arginine, fish oil, and medium-chain triglycerides were fed to mice to assess effects on bacterial translocation and survival. Animals fed arginine plus glutamine, fish oil plus arginine, or fish oil plus glutamine had the best results.
80. Daly JM, Wintraub FN, Shou J, Rosato EF, Lucia M: Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995, 221:327-338.
81. Moore FA, Moore EE, Kudsk KA, Brown RO, Bower RH, Koruda MJ, Baker CC, Barbul A: Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994, 37:607-615.
82. ®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995, 23:436-449. Patients in an intensive care unit were randomly assigned to receive an immune-enhancing diet or a standard formula. No difference in infectious complications or length of stay were seen except in patients stratified as septic and those who received goal feeds.
83. Bower RH, Cerra FB, Bersbadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR: The impact of immunonutrition. Gastroenterology 1995, 109:1713-1714.
84. Senkal M, Kemen M, Homann H-H, Eickhoff U, Baier J, Zumtobel: Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995, 161:115-122.
85. ®. Crit Care Med 1995, 23:652-659. Patients undergoing surgery for gastrointestinal cancer were randomly assigned to an immune-enhancing diet or a standard formula. Study patients demonstrated increased IgM, IgG, T cells, CD4, and CD3 cells along with B lymphocyte indices.